nach oben

Erschienen in:

01.10.2014

Conceptualizing global health-related quality of life in bladder cancer

verfasst von: Nathan Perlis, Murray Krahn, Shabbir Alibhai, Antonio Finelli, Paul Ritvo, Karen E. Bremner, Girish Kulkarni

Erschienen in: Quality of Life Research | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Patients’ values for health outcomes are central to treatment decisions in bladder cancer (BCa). An instrument incorporating the expressed preferences of BCa patients, as measured by utility, can inform clinical guidelines, resource allocation and policy decisions. Developing this instrument requires a formal conceptual framework summarizing the important domains comprising global health-related quality of life (HRQOL) in BCa.

Methods

We performed a systematic literature search on the HRQOL effects of BCa and its treatments to generate initial items in Medline, Embase, CINAHL and PsychInfo up to January 2013. Thematic synthesis was used to group related items into overarching themes (domains) and create a provisional conceptual framework. In focus groups, 12 BCa experts and 47 BCa patients with diverse clinical histories generated further items to inform the final conceptual framework.

Results

We retrieved 1,275 citations and reviewed 170 full-text publications. One hundred and sixty-nine items were extracted into 12 domains. Study investigators used the findings from the focus groups to confirm the domains and condense the list to 83 clinically important items. Functional limitations in work, travel, social interaction and sleep lowered HRQOL in many domains. The final conceptual framework included BCa-specific (urinary, sexual, bowel, body image) and generic domains (pain, vigor, social, psychological, sleep, functional, family relationship, medical care relationship).

Conclusions

A conceptual framework including 12 domains can serve as the foundation for the development of an instruments measuring global HRQOL in BCa and in particular, one that can measure patient preferences and generate utilities.

Nur mit Berechtigung zugänglich

Jemal, A., Bray, F., Centre, M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians, 61, 69–90.

Fokdal, L., Høyer, M., Meldgaard, P., & von der Maase, H. (2004). Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer. Radiotherapy and Oncology, 72(2), 139–145. doi:10.1016/j.radonc.2004.05.006.PubMedCrossRef

Efstathiou, J. A., Bae, K., Shipley, W. U., Kaufman, D. S., Hagan, M. P., Heney, N. M., et al. (2009). Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06. Journal of Clinical Oncology, 27(25), 4055–4061. doi:10.1200/JCO.2008.19.5776.PubMedCentralPubMedCrossRef

Grossman, H. B., Natale, R. B., Tangen, C. M., Speights, V. O., Vogelzang, N. J., Trump, D. L., et al. (2003). Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. The New England Journal of Medicine, 349(9), 859–866. doi:10.1056/NEJMoa022148.PubMedCrossRef

Nieder, A. M., Brausi, M., Lamm, D., O’Donnell, M., Tomita, K., Woo, H., et al. (2005). Management of stage T1 tumors of the bladder: International Consensus Panel. Urology, 66(6), 108–125.PubMedCrossRef

David, K. A., Milowsky, M. I., Ritchey, J., Carroll, P. R., & Nanus, D. M. (2007). Low incidence of perioperative chemotherapy for stage III bladder cancer 1998–2003: A report from the National Cancer Data Base. The Journal of Urology, 178(2), 451–454. doi:10.1016/j.juro.2007.03.101.PubMedCrossRef

Drummond, M. F., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005). Methods for the economic evaluation of health care programmes (3rd ed., p. 379). Oxford: Oxford University Press.

Froberg, D. G., & Kane, R. L. (1989). Methodology for measuring health-state preferences—I: Measurement strategies. Journal of Clinical Epidemiology, 42(4), 345–354.PubMedCrossRef

Torrance, G., & Feeny, D. (1989). Utilities and quality-adjusted life years. International Journal of Technology Assessment in Health, 5, 559–575.CrossRef

10.

Blinman, P., King, M., Norman, R., Viney, R., & Stockler, M. R. (2012). Preferences for cancer treatments: An overview of methods and applications in oncology. Annals of Oncology, 23(5), 1104–1110. doi:10.1093/annonc/mdr559.PubMedCrossRef

11.

Gacci, M., Saleh, O., Cai, T., Gore, J. L., D’Elia, C., Minervini, A., et al. (2013). Quality of life in women undergoing urinary diversion for bladder cancer: Results of a multicenter study among long-term disease-free survivors. Health and Quality of Life Outcomes, 11(1), 43. doi:10.1186/1477-7525-11-43.PubMedCentralPubMedCrossRef

12.

Froberg, D. G., & Kane, R. L. (1989). Methodology for measuring health-state preferences—II: Scaling methods. Journal of Clinical Epidemiology, 42(5), 459–471.PubMedCrossRef

13.

Dolan, P., Gudex, C., Kind, P., & Williams, A. (1995). A social tariff for EuroQol: Results from a UK general population survey (No. Discussion paper 138).

14.

Tomlinson, G., Bremner, K. E., Ritvo, P., Naglie, G., & Krahn, M. D. (2012). Development and validation of a utility weighting function for the patient-oriented prostate utility scale (PORPUS). Medical Decision Making, 32(1), 11–30. doi:10.1177/0272989X11407203.PubMedCrossRef

15.

Programme on Mental Health—WHOQOL Measuring Quality of Life. (1997). World health (pp. 1–13). Geneva, Switzerland.

16.

Kastner, M., Tricco, A. C., Soobiah, C., Lillie, E., Perrier, L., Horsley, T., et al. (2012). What is the most appropriate knowledge synthesis method to conduct a review? Protocol for a scoping review. BMC Medical Research Methodology, 12(1), 114. doi:10.1186/1471-2288-12-114.PubMedCentralPubMedCrossRef

17.

Krahn, M., Ritvo, P., Irvine, J., Tomlinson, G., Bezjak, A., Trachtenberg, J., et al. (2000). Construction of the patient-oriented prostate utility scale (PORPUS): A multiattribute health state classification system for prostate cancer. Journal of Clinical Epidemiology, 53(9), 920–930.PubMedCrossRef

18.

Aaronson, N. K., Calais da Silva, F., Yoshida, O., van Dam, F. S., Fossa, S. D., Miyakawa, M., et al. (1986). Quality of life assessment in bladder cancer clinical trials: Conceptual, methodological and practical issues. Progress in Clinical and Biological Research, 221, 149–170.PubMed

19.

Mansson, A., Johnson, G., & Mansson, W. (1988). Quality of life after cystectomy comparison between patients with conduit and those with continent caecal reservoir urinary diversion. British Journal of Urology, 62(3), 240–245.PubMedCrossRef

20.

Faithfull, S. (1995). “Just grin and bear it and hope that it will go away”: Coping with urinary symptoms from pelvic radiotherapy. European journal of cancer care, 4(4), 158–165.PubMedCrossRef

21.

Henningsohn, L., Wijkstrom, H., Steven, K., Pedersen, J., Ahlstrand, C., Aus, G., et al. (2003). Relative importance of sources of symptom-induced distress in urinary bladder cancer survivors. European Urology, 43(6), 651–662.PubMedCrossRef

22.

Gilbert, S. M., Dunn, R. L., Hollenbeck, B. K., Montie, J. E., Lee, C. T., Wood, D. P., et al. (2010). Development and validation of the Bladder Cancer Index: A comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer. The Journal of Urology, 183(5), 1764–1769.PubMedCrossRef

23.

Fellin, G., Graffer, U., Bolner, A., Ambrosini, G., Caffo, O., & Luciani, L. (1997). Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study. British Journal of Urology, 80(1), 44–49.PubMedCrossRef

24.

Roychowdhury, D. F., Hayden, A., & Liepa, A. M. (2003). Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. Journal of Clinical Oncology, 21(4), 673–678.PubMedCrossRef

25.

Palapattu, G. S., Haisfield-Wolfe, M. E., Walker, J. M., BrintzenhofeSzoc, K., Trock, B., Zabora, J., et al. (2004). Assessment of perioperative psychological distress in patients undergoing radical cystectomy for bladder cancer. The Journal of Urology, 172(5 Pt 1), 1814–1817.PubMedCrossRef

26.

Biermann, C. W., Schmidt, C., & Kuchler, T. (1995). Development of a life quality questionnaire in bladder cancer surgery. British Journal of Urology, 76(3), 412–413.PubMed

27.

Thulin, H., Kreicbergs, U., Wijkstrom, H., Steineck, G., & Henningsohn, L. (2010). Sleep disturbances decrease self-assessed quality of life in individuals who have undergone cystectomy. The Journal of Urology, 184(1), 198–202.PubMedCrossRef

28.

Nordstrom, G., Nyman, C. R., & Theorell, T. (1992). Psychosocial adjustment and general state of health in patients with ileal conduit urinary diversion. Scandinavian Journal of Urology and Nephrology, 26(2), 139–147.PubMed

29.

Sengelov, L., Frolich, S., Kamby, C., Jensen, N. H., & Steven, K. (2000). The functional and psychosocial status of patients with disseminated bladder cancer. Urologic Oncology, 5(1), 20–24.PubMedCrossRef

30.

Kitamura, H., Miyao, N., Yanase, M., Masumori, N., Matsukawa, M., Takahashi, A., et al. (1999). Quality of life in patients having an ileal conduit, continent reservoir or orthotopic neobladder after cystectomy for bladder carcinoma. International Journal of Urology, 6(8), 393–399.PubMedCrossRef

31.

Rabow, M., Evans, C., Weinberg, V., & Miller, B. (2011). Symptom burden for patients with bladder cancer and their family caregivers: Preliminary results (753). Journal of Pain and Symptom Management, 41(1), 304–305.CrossRef

32.

Colwell, J. C. (2005). Dealing with ostomies: Good care, good devices, good quality of life. The Journal of Supportive Oncology, 3(1), 72–74.PubMed

33.

Botteman, M. F., Pashos, C. L., Redaelli, A., Laskin, B., & Hauser, R. (2003). The health economics of bladder cancer: A comprehensive review of the published literature. Pharmacoeconomics, 21(18), 1315–1330.PubMedCrossRef

34.

Gilbert, S. M., Wood, D. P., Dunn, R. L., Weizer, A. Z., Lee, C. T., Montie, J. E., et al. (2007). Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI). Cancer, 109(9), 1756–1762. doi:10.1002/cncr.22556.PubMedCrossRef

35.

Cookson, M. S., Dutta, S. C., Chang, S. S., Clark, T., Smith, J. A. J., & Wells, N. (2003). Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: Development and validation of a new disease specific questionnaire. The Journal of Urology, 170(5), 1926–1930.PubMedCrossRef

36.

Jefford, M., Karahalios, E., Pollard, A., Baravelli, C., Carey, M., Franklin, J., et al. (2008). Survivorship issues following treatment completion–results from focus groups with Australian cancer survivors and health professionals. Journal of Cancer Survivorship: Research and Practice, 2(1), 20–32. doi:10.1007/s11764-008-0043-4.CrossRef

37.

Helman, C. G. (1995). The body image in health and disease: Exploring patients’ maps of body and self. Patient Education and Counseling, 26, 169–175.PubMedCrossRef

38.

Mechanic, D. (2004). In my chosen doctor i trust: And that trust transfers from doctors to organisations. British Medical Journal, 329(7480), 1418–1419.PubMedCentralPubMedCrossRef

39.

Rasmussen, D. M., & Elverdam, B. (2008). The meaning of work and working life after cancer: An interview study. Psycho-Oncology, 17, 1232–1238. doi:10.1002/pon.PubMedCrossRef

Titel: Conceptualizing global health-related quality of life in bladder cancer
verfasst von: Nathan Perlis
Murray Krahn
Shabbir Alibhai
Antonio Finelli
Paul Ritvo
Karen E. Bremner
Girish Kulkarni
Publikationsdatum: 01.10.2014
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 8/2014
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-014-0685-9

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2014

Improving the mapping of condition-specific health-related quality of life onto SF-6D score

Danish population-based reference data for the EORTC QLQ-C30: associations with gender, age and morbidity

Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B

The effects of anxiety sensitivity, pain hypervigilance, and pain catastrophizing on quality of life outcomes of patients with chronic pain: a preliminary, cross-sectional analysis

Health-related quality of life following radical prostatectomy: long-term outcomes

A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA